As a national high-tech enterprise, Celconta Group has a hard-core consultant team and research and development
team, a GMP-like laboratory of more than 10,000 square meters and a complete
quality control system. The R&D personnel have rich practical experience in
cell drug research and development, clinical research, etc., and the quality
control personnel have the background of a large pharmaceutical factory. The preparation of UCMSC(umbilical cord mesenchymal stem
cell) passed the quality review inspection of National Institutes for Food and
Drug Control.
Celconta Group takes advantage
of its own advantages in cell drug research and development and production, to undertake
the process development and production functions of cell drug companies, so
that cell drug companies can focus more on cell drug research and development,
and develop more and better cell drugs for the benefit of the majority of
patients.
